Mail delivery failed: returning message to sender

Mail Delivery System <[email protected]> Thu, 05 Oct 2006 22:46:35 -0700
Newsgroups gmane.comp.file-systems.intermezzo.announce,gmane.spam.detected
Message-ID <[email protected]>
This message was created automatically by mail delivery software.

A message that you sent could not be delivered to one or more of its
recipients. This is a permanent error. The following address(es) failed:

  [email protected]
    SMTP error from remote mailer after RCPT TO:<[email protected]>:
    host mail.sourceforge.net [66.35.250.206]: 451-Could not complete sender verify callout
    451-Could not complete sender verify callout for
    451-<[email protected]>.
    451-The mail server(s) for the domain may be temporarily unreachable, or
    451-they may be permanently unreachable from this server. In the latter case,
    451-you need to change the address or create an MX record for its domain
    451-if : retry timeout exceeded

------ This is a copy of the message, including all the headers. ------

Return-path: <[email protected]>
Received: from adsl196-230-78-206-196.adsl196-3.iam.net.ma ([196.206.78.230])
	by externalmx-1.sourceforge.net with esmtp (Exim 4.41)
	id 1GUCYN-0005Gy-UR
	for [email protected]; Sun, 01 Oct 2006 18:25:09 -0700
Received: from [178.181.217.215] (helo=[12608726])
        by adsl196-230-78-206-196.adsl196-3.iam.net.ma with smtp (Exim 4.60 (FreeBSD))
        (envelope-from <[email protected]>)
        id 07Q6n-xRA13JEY-KP0
        for [email protected]; Mon, 02 Oct 2006 01:24:55 +0000
Received: from le-vin-bio.com (600318280 [88827135801])
        by mx1.le-vin-bio.com (Qmailv1) with ESMTP id YMMJF52M
        for <[email protected]>; Mon, 02 Oct 2006 00:35:07 -0200
Date: Mon, 02 Oct 2006 00:35:07 -0200
From: "Clifford Foster" <[email protected]>
X-Mailer: MailGate v3.0
X-Priority: 3
Message-ID: <[email protected]>
To: [email protected]
Subject: all, right!  Gorov was could see.
MIME-Version: 1.0
Content-Type: text/plain; charset=iso-8859-1
Content-Transfer-Encoding: 7bit
X-Spam-Score: 4.8 (++++)
X-Spam-Report: Spam Filtering performed by sourceforge.net.
	See http://spamassassin.org/tag/ for more details.
	Report problems to https://sf.net/tracker/?func=add&group_id=1&atid=200001
	0.1 HELO_DYNAMIC_DHCP      Relay HELO'd using suspicious hostname (DHCP)
	2.8 HELO_DYNAMIC_IPADDR    Relay HELO'd using suspicious hostname (IP addr 1)
	0.0 SF_CHICKENPOX_PERIOD   BODY: Text interparsed with .
	0.0 SF_CHICKENPOX_MINUS    BODY: Text interparsed with -
	0.0 SF_CHICKENPOX_AMPERSAND BODY: Text interparsed with &
	1.8 STOCK_ALERT            BODY: Offers a alert about a stock
	0.0 SF_CHICKENPOX_APOSTROPHE BODY: Text interparsed with '
	0.1 RCVD_IN_SORBS_DUL      RBL: SORBS: sent directly from dynamic IP address
	[196.206.78.230 listed in dnsbl.sorbs.net]

HOT STOCK ALERT - THIS ONE IS STILL CLIMBING THE STOCK CHARTS ALERT --
BREAKING MARKET NEWS REPORT ---- PGCN.OB

Company: Pingchuan Pharmaceutical Inc.
Ticker: PGCN.OB
Current Price: $.26
5-Day Target: $1.5 - $2
Rating: 10(10)
Recommendation: S T R 0 N G -  B U Y !!

This quick rising stock is a good long term winner. This stock is
going high due to superb business solutions and creative partnerships
in the business world.
Could this company be the next PFIZER??


Pingchaun Pharmaceuticals disributes its medications to over 50
percent of CHINA and has a tremendous presence via exports to U.S.A,
Russia, Japan and South-Eastern Asia.  They have partnerships with the
biggest drugstores, equivalent in the US to SAV-ON, CVS, RITE-AID,
etc.  With BIG NEWS anticipated this coming WEEK we strongly advise
you to get in EARLY and issue
a 10/10 Alert.


About Pingchuan Pharmaceutical Inc.
Pingchuan Pharmaceutical Inc. ("PINGCHUAN") is a modernized
pharmaceutical manufacturer with first-class medical R&D ability,
pioneered medicine products, and well-established marketing network.
Since its establishment, PINGCHUAN has focused its businesses on
diabetes medicine and its medical products. The products of PINGCHUAN
include health care products, varieties of medicine, as well as
medical apparatus. Kang Da Glycosuria Capsule is a successful product
of PINGCHUAN for treating diabetes, which was first developed in 1998
and introduced to the market in 2001. PINGCHUAN has well-established
marketing network and sale branches, which include about 180,000
retail pharmacies /drugstores across China, agency network in major
cities like Beijing, Shanghai, Guangzhou, and Xi'an, special counter
sale at drug chain stores in key regions, residence community clinic
sale and promotion, as well as internet marketing through the
company's website. The marketing network of PINGCHUAN covers more than
50 percent districts
of China and exports to US, Japan, Russia, and south-eastern Asia.

Dont miss the boat, this is a new issue, is thinly traded and could
move up quickly.  We anticipate that shares of PGCN will be much
higher in the short-term.  ACT NOW!

Remember the gains from our recent recommendations... Do not miss out,
Put PGCN.OB on your radar's now. Good luck and trade out at the top!!



-------------------------------------------------------------------------
Take Surveys. Earn Cash. Influence the Future of IT
Join SourceForge.net's Techsay panel and you'll get the chance to share your
opinions on IT & business topics through brief surveys -- and earn cash
http://www.techsay.com/default.php?page=join.php&p=sourceforge&CID=DEVDEV